Drug combination for assisting in blood lipid reduction

A technology for assisting in reducing blood lipids and compositions, which is applied in the field of pharmaceutical compositions for assisting in reducing blood lipids. It can solve the problems of toxic and side effects of western medicines, and achieve the effects of being convenient to take, ensuring effective ingredients, and being easy to take for a long time

Inactive Publication Date: 2016-11-16
广西泰和制药有限公司
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

They are favored by everyone for their quick onset and definite curative effect in controlling blood lipids, but western medicines have different degrees of toxic and side effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Drug combination for assisting in blood lipid reduction
  • Drug combination for assisting in blood lipid reduction
  • Drug combination for assisting in blood lipid reduction

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0028]

[0029] Take coarsely crushed green tea, pass through a 12-mesh sieve, and set aside; take coarsely crushed Alisma, pass through a 24-mesh sieve, collect 1 / 2 amount of Alisma, and set aside; take kudzu root, salvia, astragalus, mulberry leaves, Jiaogulan, lotus leaves and Add water to extract Alisma 3 times, add 12 times the amount of water each time, 1.5 hours each time, filter, combine the filtrates, concentrate under reduced pressure to a clear paste with a relative density of 1.30-1.35 (measured at 60°C), and dry under reduced pressure Paste, pulverize, pass through 80 mesh sieves, get dry pasta powder for subsequent use. Mix the above-mentioned dry paste powder with green tea powder, Alisma powder and appropriate amount of starch, use 60% ethanol to make a soft material, granulate, dry, granulate, pack into capsules, and make 10,000 capsules.

Embodiment 2

[0031]

[0032] Take Alisma coarsely crushed and set aside; take green tea, Alisma coarse powder, kudzu root, salvia miltiorrhiza, astragalus, mulberry leaves, Gynostemma pentaphyllum, and lotus leaves, add water and extract 3 times, add 12 times the amount of water each time, and filter for 1.5 hours each time. The filtrates were combined, concentrated under reduced pressure to a clear paste with a relative density of 1.30 to 1.35 (measured at 60°C), dried under reduced pressure to form a dry paste, pulverized, and passed through an 80-mesh sieve to obtain a dry paste for future use. Mix the above-mentioned dry paste powder with appropriate amount of powdered sugar and dextrin, make soft material with 60% ethanol, granulate, dry, and granulate to make 1000 bags.

Embodiment 3

[0034]

[0035] Take coarsely crushed green tea, pass through a 12-mesh sieve, and set aside; take coarsely crushed Alisma, pass through a 24-mesh sieve, collect 1 / 2 amount of Alisma, and set aside; take kudzu root, salvia, astragalus, mulberry leaves, Jiaogulan, lotus leaves and Add water to extract Alisma 3 times, add 12 times the amount of water each time, 1.5 hours each time, filter, combine the filtrates, concentrate under reduced pressure to a clear paste with a relative density of 1.30-1.35 (measured at 60°C), and dry under reduced pressure. Paste, pulverize, pass through 80 mesh sieves, get dry pasta powder for subsequent use. Mix the above-mentioned dry cream powder with green tea powder and Alisma powder, make a soft material with 60% ethanol, granulate, dry, granulate, put into tea bags, and make 1000 bags.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a drug combination for assisting in blood lipid reduction. The drug combination is prepared from the following raw materials in parts by weight, 110-130 parts of kudzu vine roots, 110-130 parts of roots of red-rooted salvia, 70-90 parts of rhizoma alismatis, 50-70 parts of mulberry leaves, 30-50 parts of lotus leaves and 90-110 parts of green tea which are active components. The drug combination has good blood lipid reduction assisting effects and overcomes the shortcomings of an existing drug for assisting in blood lipid reduction.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese medicine, in particular to a pharmaceutical composition for assisting in lowering blood fat. Background technique [0002] With the acceleration of the industrialization process, people's material life has been greatly improved. While enjoying the material civilization brought about by economic development, human beings feel more and more that the doom brought by material enjoyment is approaching. Hyperlipidemia caused by one's own bad life behavior has become the main threat factor of modern diseases. Atherosclerosis caused by hyperlipidemia is the main cause of coronary heart disease, hypertension and cardiovascular and cerebrovascular diseases, and about 12 million people die of cardiovascular diseases and cerebral apoplexy in the world every year. In fact, hyperlipidemia has now become the first invisible killer of human health. Therefore controlling and treating hyperlipidemia i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/884A61P3/06
CPCA61K36/488A61K36/537A61K36/605A61K36/62A61K36/82A61K36/884A61K2300/00
Inventor 陈治伟张喜均甘铁汉韩宇强
Owner 广西泰和制药有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products